Projects & Events
20 years of research on antibodies become a competitive industrial activity
Mediapharma s.r.l., an italian spin-off supported by INNOVA's seed capital company, INVENT s.a.s, successfully brings the results of 20 years of research on monoclonal antibodies to the pharmaceutical market, a breakthrough for the diagnosis and cancer treatment.
Listen to the interview of Professor Iacobelli transmitted on RAI3 Leonardo News on 25-01-2010 (in italian):
News & Events
-
14.05 - Open call for tenders for mobile application development for Cult-Ways
-
30.04 - Training on SME Development in Science and Technology, 8-10 May 2012, Pretoria, South Africa
-
13.04 - Labor Srl at the 14th annual Hybrid SMALL FUEL CELLS 2012 symposium,18 July 2012, Boston (USA)
-
10.04 - NET-EUCEN validation campaigns, May 2012 to March 2013, Brussels, Belgium
-
17.03 - Partnership Forum PA-Labor for innovation consultancy services at the Open Innovation Lab 2012
Press Coverage
Publications
Plan and manage a science park in the Mediterranean", a guidebook for decision makers
This guidebook provides science park decision makers with a number of
tools helping them manage a park.
Read more
See all our publications






